 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation |
| Keun-Sik Hong |
|
J Stroke. 2019;21(3):259-275. Published online September 30, 2019 DOI: https://doi.org/10.5853/jos.2019.01970 |
|
Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation Journal of Stroke. 2019;21(3):259-275  Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk European Heart Journal. 2021;42(Supplement_1): Risk of Major Bleeding and Thromboembolism in Asian Atrial Fibrillation Patients Using Non-vitamin K Oral Anticoagulants Versus Warfarin . 2021; Secondary Prevention of Stroke with Atrial Fibrillation by New Oral Anticoagulants Treatment of Non-vitamin K Antagonist Oral Anticoagulants. 2016;1-10 Benefits of non–vitamin K antagonist oral anticoagulants in patients with atrial fibrillation go beyond stroke prevention Heart Rhythm. 2017;14(4):606-607 P471Experience with the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation and a high risk of hemorrhagic complications EP Europace. 2020;22(Supplement_1): Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants Clinical Interventions in Aging. 2015;1431 Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF? European Heart Journal. 2019;40(46):3754-3756 Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function Thrombosis Research. 2017;150:123-130 Non-vitamin K antagonist oral anticoagulants (NOAC) in nonvalvular atrial fibrillation – in-group comparison Prospects in Pharmaceutical Sciences. 2022;20(1):26-31 |
